News

Date: October 10 – 12 2023

Venue: Basel

We are pleased to announce our participation in the upcoming Festival of Biologics 2023 (FOB) from October 10th to 12th in Basel, Switzerland.

Our team at Voxcan will be joining forces with Oncofactory, both part of the ERBC Group.

Raafat Fares, Scientific Director, ERBC group, Eleonora Mattei, Scientific Business Development Manager, ERBC Group and Julia Matonti, Business Development Manager, ERBC Group, Voxcan, are looking forward to meeting you to discuss our extensive non-clinical expertise and how we can build a new partnership to accelerate your candidate’s time to market in line with the 3Rs principles.

We invite you to discover how we can support your needs with our cutting-edge offerings:

• Including non-invasive in vitro and in vivo models, coupled with high-resolution imaging across various small animal species. These capabilities are tailored for non-clinical drug development, covering areas such as oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases, and medical devices. We specialize in conducting efficacy, biodistribution, mechanistic, and proof of concept studies.
• And a unique AVI-PDX platform, based on the generation of patient tumor replicas in avian embryos, combined with state-of-the-art 3D microscopy and large-scale molecular analysis for rapid efficacy assessment and in-depth mechanism of action characterization to evaluate therapeutic candidates.

Visit our team at the French Biotherapy Pavilion, promoted by Choose France, on booth #6.

With the support of the Région Auvergne-Rhône-Alpes, and Lyonbiopôle.